Stanford Scholars Explore Generative AI in Drug Discovery

Stanford researchers led by James Zou published an article in the journal Circulation, systematically exploring the potential of generative and agentic AI in drug discovery. The research highlights how AI is transforming translational medicine from target screening to clinical trial recruitment.

2026-07-30 ~ 2026-08-01 · 3 related posts

• Agentic AI Reshapes Drug Discovery: From Target Selection to Clinical Trials — james_y_zou · 2026-07-30
• Circulation Journal Reviews Generative and Agentic AI in Drug Discovery — james_y_zou · 2026-07-31
• Stanford Scholars Explore Generative and Agentic AI for Drug Discovery in Circulation — james_y_zou · 2026-08-01